Acquisition by Reese Lou of 620000 shares of Vaxxinity subject to Rule 16b-3
VAXXDelisted Stock | USD 2.72 0.19 6.53% |
Slightly above 61% of Vaxxinity's investor base is looking to short. The analysis of overall sentiment of trading Vaxxinity pink sheet suggests that many investors are alarmed at this time. Vaxxinity's investing sentiment can be driven by a variety of factors including economic data, Vaxxinity's earnings reports, geopolitical events, and overall market trends.
Vaxxinity |
Filed transaction by Vaxxinity Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Vaxxinity Fundamental Analysis
We analyze Vaxxinity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxxinity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxxinity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Vaxxinity is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Vaxxinity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vaxxinity pink sheet to make a market-neutral strategy. Peer analysis of Vaxxinity could also be used in its relative valuation, which is a method of valuing Vaxxinity by comparing valuation metrics with similar companies.
Peers
Vaxxinity Related Equities
PASG | Passage Bio | 68.66 | ||||
LYRA | Lyra Therapeutics | 10.53 | ||||
VINC | Vincerx Pharma | 7.69 | ||||
VIGL | Vigil Neuroscience | 7.39 | ||||
ETON | Eton Pharmaceuticals | 6.20 | ||||
IOBT | IO Biotech | 4.71 | ||||
CMPX | Compass Therapeutics | 4.49 | ||||
TARS | Tarsus Pharmaceuticals | 3.17 | ||||
BCAB | Bioatla | 2.44 | ||||
HOWL | Werewolf Therapeutics | 1.52 | ||||
STTK | Shattuck Labs | 0.92 | ||||
ACRV | Acrivon Therapeutics, | 0.80 | ||||
TVTX | Travere Therapeutics | 0.59 | ||||
ALDX | Aldeyra | 0.81 | ||||
PEPG | PepGen | 0.98 | ||||
ELYM | Eliem Therapeutics | 1.30 | ||||
GPCR | Structure Therapeutics | 1.78 | ||||
TYRA | Tyra Biosciences | 2.00 | ||||
ERAS | Erasca | 2.05 | ||||
THRD | Third Harmonic | 2.67 | ||||
PRTC | PureTech Health | 5.04 | ||||
APLT | Applied Therapeutics | 76.31 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Vaxxinity Pink Sheet
If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |